Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1968 1
1971 2
1972 1
1973 2
1974 2
1975 1
1976 2
1977 3
1978 1
1979 7
1980 9
1981 8
1982 4
1983 4
1984 8
1985 3
1986 5
1987 3
1988 5
1989 3
1990 3
1991 3
1992 3
1993 4
1994 3
1995 3
1996 1
1997 2
1998 3
1999 2
2000 3
2001 5
2002 9
2003 5
2004 5
2005 3
2006 6
2007 9
2008 8
2009 10
2010 11
2011 8
2012 14
2013 17
2014 34
2015 30
2016 21
2017 31
2018 45
2019 55
2020 53
2021 57
2022 58
2023 61
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

585 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).
Titov I, Wunderink RG, Roquilly A, Rodríguez Gonzalez D, David-Wang A, Boucher HW, Kaye KS, Losada MC, Du J, Tipping R, Rizk ML, Patel M, Brown ML, Young K, Kartsonis NA, Butterton JR, Paschke A, Chen LF. Titov I, et al. Among authors: rizk ml. Clin Infect Dis. 2021 Dec 6;73(11):e4539-e4548. doi: 10.1093/cid/ciaa803. Clin Infect Dis. 2021. PMID: 32785589 Free PMC article. Clinical Trial.
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C, Back J, Hendricks O, Vedder D, Rannio T, Grenholm E, Ljoså MK, Brodin E, Lindegaard H, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Bay Laurbjerg T, Bakland G, Olsen IC, Haavardsholm EA, Lampa J; NORD-STAR study group. Østergaard M, et al. Among authors: rizk m. Ann Rheum Dis. 2023 Oct;82(10):1286-1295. doi: 10.1136/ard-2023-224116. Epub 2023 Jul 9. Ann Rheum Dis. 2023. PMID: 37423647 Clinical Trial.
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial.
Hetland ML, Haavardsholm EA, Rudin A, Nordström D, Nurmohamed M, Gudbjornsson B, Lampa J, Hørslev-Petersen K, Uhlig T, Grondal G, Østergaard M, Heiberg MS, Twisk J, Lend K, Krabbe S, Hyldstrup LH, Lindqvist J, Hultgård Ekwall AK, Grøn KL, Kapetanovic M, Faustini F, Tuompo R, Lorenzen T, Cagnotto G, Baecklund E, Hendricks O, Vedder D, Sokka-Isler T, Husmark T, Ljoså MA, Brodin E, Ellingsen T, Söderbergh A, Rizk M, Olsson ÅR, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Laurberg TB, Bakland G, Olsen IC, van Vollenhoven R; NORD-STAR study group. Hetland ML, et al. Among authors: rizk m. BMJ. 2020 Dec 2;371:m4328. doi: 10.1136/bmj.m4328. BMJ. 2020. PMID: 33268527 Free PMC article. Clinical Trial.
Gallstones: Watch and wait, or intervene?
Ibrahim M, Sarvepalli S, Morris-Stiff G, Rizk M, Bhatt A, Walsh RM, Hayat U, Garber A, Vargo J, Burke CA. Ibrahim M, et al. Among authors: rizk m. Cleve Clin J Med. 2018 Apr;85(4):323-331. doi: 10.3949/ccjm.85a.17035. Cleve Clin J Med. 2018. PMID: 29634468 Free article. Review.
Immune-related biomarkers and suicidal behaviors: A meta-analysis.
Neupane SP, Daray FM, Ballard ED, Galfalvy H, Itzhaky L, Segev A, Shelef A, Tene O, Rizk MM, Mann JJ, Zalsman G. Neupane SP, et al. Among authors: rizk mm. Eur Neuropsychopharmacol. 2023 Oct;75:15-30. doi: 10.1016/j.euroneuro.2023.05.009. Epub 2023 Jun 23. Eur Neuropsychopharmacol. 2023. PMID: 37356288 Free article. Review.
Quality indicators for ERCP.
Adler DG, Lieb JG 2nd, Cohen J, Pike IM, Park WG, Rizk MK, Sawhney MS, Scheiman JM, Shaheen NJ, Sherman S, Wani S. Adler DG, et al. Among authors: rizk mk. Gastrointest Endosc. 2015 Jan;81(1):54-66. doi: 10.1016/j.gie.2014.07.056. Epub 2014 Dec 2. Gastrointest Endosc. 2015. PMID: 25480099 Review. No abstract available.
Quality indicators for colonoscopy.
Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, Lieb JG 2nd, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Wani S, Weinberg DS. Rex DK, et al. Among authors: rizk mk. Gastrointest Endosc. 2015 Jan;81(1):31-53. doi: 10.1016/j.gie.2014.07.058. Epub 2014 Dec 2. Gastrointest Endosc. 2015. PMID: 25480100 Review. No abstract available.
Quality indicators for EUS.
Wani S, Wallace MB, Cohen J, Pike IM, Adler DG, Kochman ML, Lieb JG 2nd, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Tokar JL. Wani S, et al. Among authors: rizk mk. Gastrointest Endosc. 2015 Jan;81(1):67-80. doi: 10.1016/j.gie.2014.07.054. Epub 2014 Dec 2. Gastrointest Endosc. 2015. PMID: 25480097 Review. No abstract available.
585 results